• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年人体内2-[18F]氟-2-脱氧-D-葡萄糖对膀胱壁的辐射剂量。

Radiation dose to the bladder wall from 2-[18F]fluoro-2-deoxy-D-glucose in adult humans.

作者信息

Dowd M T, Chen C T, Wendel M J, Faulhaber P J, Cooper M D

机构信息

University of Chicago, Department of Radiology, Illinois 60637.

出版信息

J Nucl Med. 1991 Apr;32(4):707-12.

PMID:2013811
Abstract

Accurate determination of the radiation dose to the bladder wall from 2-[18F]fluoro-2-deoxy-D-glucose (2-[18F]FDG) is important because the bladder is the critical organ in radiotracer studies using 2-[18F]FDG. The radiation dose to the bladder wall from injected 2-[18F]FDG was estimated using both a dynamic bladder model and the conventional MIRD model. The dynamic model takes into account the excretion rate, the varying size of the bladder, the volume at injection, and an estimated bladder time activity curve. Our data from 302 adult subjects in a five-year period indicate that when the bladder is large at the time of injection, the dose to the bladder is greatly reduced. The absorbed dose of the bladder based on the dynamic model for an initial volume of 450 ml is 0.16 +/- 0.06 rad/mCi, while that for an initial volume of 200 ml is calculated to be 0.37 +/- 0.18 rad/mCi. The MIRD model estimates an average value of 0.35 +/- 0.16 rad/mCi for the 302 cases.

摘要

准确测定膀胱壁对2-[¹⁸F]氟-2-脱氧-D-葡萄糖(2-[¹⁸F]FDG)的辐射剂量很重要,因为在使用2-[¹⁸F]FDG的放射性示踪剂研究中,膀胱是关键器官。使用动态膀胱模型和传统的MIRD模型估计了注入的2-[¹⁸F]FDG对膀胱壁的辐射剂量。动态模型考虑了排泄率、膀胱大小的变化、注射时的体积以及估计的膀胱时间-活度曲线。我们在五年期间对302名成年受试者的数据表明,注射时膀胱较大时,膀胱所受剂量会大幅降低。基于动态模型,初始体积为450 ml时膀胱的吸收剂量为0.16±0.06 rad/mCi,而初始体积为200 ml时计算得出为0.37±0.18 rad/mCi。MIRD模型对这302例病例估计的平均值为0.35±0.16 rad/mCi。

相似文献

1
Radiation dose to the bladder wall from 2-[18F]fluoro-2-deoxy-D-glucose in adult humans.成年人体内2-[18F]氟-2-脱氧-D-葡萄糖对膀胱壁的辐射剂量。
J Nucl Med. 1991 Apr;32(4):707-12.
2
Estimated radiation dose to the newborn in FDG-PET studies.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)研究中新生儿的估计辐射剂量。
J Nucl Med. 1996 Feb;37(2):387-93.
3
MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations. Task Group of the MIRD Committee, Society of Nuclear Medicine.《核医学与分子影像剂量学手册》第14号修订版:用于辐射剂量计算的动态膀胱模型。核医学学会MIRD委员会任务组
J Nucl Med. 1999 Apr;40(4):102S-123S.
4
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.在使用当前[18F]氟脱氧葡萄糖法动力学模型估计局部脑葡萄糖利用时,组织异质性所引入的误差。
J Cereb Blood Flow Metab. 1992 Sep;12(5):823-34. doi: 10.1038/jcbfm.1992.114.
5
Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.使用卡比多巴预处理的氟-18-氟-L-多巴剂量测定法。
J Nucl Med. 1998 Nov;39(11):1884-91.
6
Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies.正电子发射断层显像(PET)研究中静脉注射氟-18-氟脱氧葡萄糖后人体吸收剂量的估算。
J Nucl Med. 1991 Apr;32(4):699-706.
7
[Toxicity and radiation dosage of 2-(18F)-2-desoxy-D-glucose in positron emission tomography].[正电子发射断层扫描中2-(18F)-2-脱氧-D-葡萄糖的毒性与辐射剂量]
Acta Med Austriaca. 1998;25(1):1-6.
8
Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.2-[18F]氟-A-85380在人体PET成像研究中的全身辐射剂量测定
Nucl Med Biol. 2005 Nov;32(8):869-74. doi: 10.1016/j.nucmedbio.2005.06.005.
9
The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man.2-[F-18]氟-2-脱氧-D-葡萄糖在人体中的辐射剂量测定
J Nucl Med. 1982 Jul;23(7):613-7.
10
MIRD Pamphlet No. 14: a dynamic urinary bladder model for radiation dose calculations.
J Nucl Med. 1992 May;33(5):783-802.

引用本文的文献

1
Estimation of the Internal Dose Imparted by F-Fluorodeoxyglucose to Tissues by Using Fricke Dosimetry in a Phantom and Positron Emission Tomography.通过在体模中使用弗里克剂量测定法和正电子发射断层扫描估算¹⁸F-氟脱氧葡萄糖给予组织的内照射剂量
Front Nucl Med. 2022 Feb 14;2:815141. doi: 10.3389/fnume.2022.815141. eCollection 2022.
2
Assessing the applicability of PMOD residence times model for PET image-based radiation dosimetry.评估 PMOD 居留时间模型在基于 PET 图像的辐射剂量学中的适用性。
Sci Rep. 2023 Nov 8;13(1):19387. doi: 10.1038/s41598-023-46822-5.
3
Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement?
基于全身PET/CT长期测量的器官活性进行的F-18 FDG PET检查中的内照射剂量测定:与短期测量有何不同?
EJNMMI Phys. 2021 Jul 15;8(1):51. doi: 10.1186/s40658-021-00395-2.
4
Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.基于小鼠全身 PET 成像的 [18F]Mefway 生物分布和剂量评估。
Mol Imaging Biol. 2013 Apr;15(2):222-9. doi: 10.1007/s11307-012-0582-y.
5
Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review.诊断核医学中常用放射性药物的生物动力学和剂量学——综述。
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2269-81. doi: 10.1007/s00259-011-1904-z. Epub 2011 Aug 30.
6
Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT.通过全身PET/CT测定缺氧标志物18F-HX4在猴子和人类中的生物分布及辐射剂量学。
Nucl Med Commun. 2010 Dec;31(12):1016-24. doi: 10.1097/MNM.0b013e3283407950.
7
Fetal dose estimates for (18)F-fluoro-L-thymidine using a pregnant monkey model.使用怀孕猴子模型估算 (18)F-氟代胸苷的胎儿剂量。
J Nucl Med. 2010 Feb;51(2):288-92. doi: 10.2967/jnumed.109.068734. Epub 2010 Jan 15.
8
Biodistribution, toxicity and radiation dosimetry studies of the serotonin transporter radioligand 4-[18F]-ADAM in rats and monkeys.大鼠和猴子中 5-羟色胺转运体放射性配体 4-[18F]-ADAM 的生物分布、毒性和辐射剂量学研究。
Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):545-55. doi: 10.1007/s00259-009-1281-z. Epub 2009 Oct 10.
9
Radiation exposure during transmission measurements: comparison between CT- and germanium-based techniques with a current PET scanner.透射测量期间的辐射暴露:基于CT和锗的技术与当前PET扫描仪的比较
Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):38-43. doi: 10.1007/s00259-003-1327-6. Epub 2003 Oct 8.
10
PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs).
Eur J Nucl Med. 1995 Dec;22(12):1420-32. doi: 10.1007/BF01791152.